Will Nigeria’s heart beat faster or falter in 2026?

Somewhere in Jigawa, a community health worker is waiting for the blood pressure cuffs that never arrived. In Mushin, a patient has rationed her last tablet of Amlodipine for the third consecutive month. These are not edge cases; they are the lived reality behind Nigeria’s headline health numbers. When the Presidency released the 2026 federal budget for health – a record N2.48tn, signed into law by the President—it was easy to feel a cautious optimism. But for the estimated 38 per cent of Nigerian adults living with hypertension (four in 10, per the Federal Ministry of Health and Social Welfare’s 2025 State of Health of the Nation report), the figure on paper matters far less than whether those trillions ever reach the facility level.

Hypertension is no longer a “silent killer” in Nigeria; it is a loud, fiscal emergency. It is an economic tax that drains the productivity of our workforce and the savings of our elderly. With the current prevalence rates, we are looking at a national heart that is struggling to pump against the resistance of underfunding and policy inertia.

The N2.48tn allocation represents roughly 4.2 per cent of the total 2026 budget. While nominally higher than 2024 levels, we remain far from breathing at full capacity under the 15 per cent Abuja Declaration target, a commitment African heads of state made in Abuja in 2001—now 25 years unanswered. When adjusted for inflation and the weakened Naira, this “record” allocation barely treads water.

The real tragedy, however, isn’t just the size of the pie; it is the “leaky pipe” of fund releases. Historically, Nigeria’s health sector suffers from a massive gap between appropriation (what is promised) and release (what is actually sent to the bank). In previous cycles, capital projects for Non-Communicable Diseases have seen release rates as low as 15 per cent. For a hypertensive patient, a 15 per cent release of their medication is a death sentence.

Fortunately, 2026 presents a unique policy window. The National Hypertension Control Initiative has provided a blueprint for integrating hypertension care into the Basic Health Care Provision Fund. This is our best shot. By leveraging the BHCPF, the government can move away from one-off, event-driven screening exercises that generate headlines but no continuity of care and toward a sustainable model where every Nigerian, regardless of income, can access affordable anti-hypertensive drugs at their local PHC.

But this requires a shift in how we view health financing. We must stop treating hypertension care as a “social cost” and start seeing it as “human capital infrastructure.”

The economics are straightforward: a population burdened by preventable cardiovascular disease is a less productive, less investable economy. Every naira spent keeping a working-age Nigerian’s blood pressure-controlled returns multiples in preserved labour, reduced catastrophic health expenditure, and avoided stroke-related disability costs. When a 45-year-old breadwinner suffers a stroke due to unmanaged high blood pressure, the loss to the Nigerian GDP is far greater than the cost of a year’s supply of Amlodipine.

To ensure the 2026 budget isn’t just another exercise in budgetary aesthetics, we need three things:

Ring-fencing NCD funds: A specific percentage of the BHCPF must be legally protected for hypertension and diabetes management.

State-level accountability: The federal government cannot do it alone. States must match federal allocations. Kano State’s integration of hypertension screening into its primary care network has demonstrated measurable gains in early detection – a model the remaining 35 states must be incentivised to replicate.

Digital tracking: We need real-time public dashboards to track the release of health funds from the Treasury to the facility level.

The 2026 budget is a test of our national pulse. If we continue the cycle of high-sounding promises and low-level releases, the burden of hypertension will eventually break the back of our healthcare system. However, if we seize this window to fund the NHCI fully and fix the release bottleneck, we might finally hear the steady, healthy beat of a nation on the mend.

Nigeria’s heart is under pressure. Whether it beats faster with progress or falters under the weight of neglect depends entirely on what happens after the signed budget.

Emmanuel Alhassan is a Professor of Psychology at the Nasarawa State University, Keffi and Country Lead, Health Systems Strengthening, Global Health Advocacy Incubator in Nigeria and Mrs Juliana Abude-Aribo, Executive Director, LISDEL